SMARCD2 Antibodies

Santa Cruz Biotechnology features a diverse variety of SMARCD2 monoclonal antibodies for research focused on understanding SMARCD2 protein function. SMARCD2 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA).SMARCD2, also known as BAF60b, is a critical component of the SWI/SNF chromatin remodeling complex, which plays a vital role in regulating gene expression and maintaining chromatin structure. SMARCD2 participates in various cellular processes, including differentiation, proliferation, and response to DNA damage, making it essential for normal cellular function and development. Dysregulation of SMARCD2 has been implicated in several diseases, including cancer, highlighting its significance as a target for therapeutic intervention. Research has shown that SMARCD2 influences cell cycle progression and transcriptional regulation in multiple cell types. Understanding SMARCD2's molecular interactions and regulatory mechanisms can provide crucial insights into disease pathways and potential treatments. SMARCD2 expression patterns vary across different tissues and developmental stages, suggesting diverse biological roles. Santa Cruz Biotechnology monoclonal antibodies enable researchers to advance scientific understanding of SMARCD2's role in cellular processes and disease mechanisms, contributing to the development of new therapeutic strategies.